Skip to main content
SPRC
NASDAQ Life Sciences

SciSparc Receives Nasdaq Non-Compliance Notice for Minimum Stockholders' Equity

Analisis de IA por Wiseek
Sentimiento info
Negativo
Importancia info
8
Precio
$1.45
Cap. de mercado
$4.769M
Min. 52 sem.
$1.25
Max. 52 sem.
$19.089
Market data snapshot near publication time

summarizeResumen

SciSparc Ltd. has received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement, reporting a negative equity balance of approximately $(81,000) as of June 30, 2025, significantly below the $2.5 million threshold. This notice highlights severe financial distress and poses a material risk to the company's Nasdaq listing if not resolved. While the company expects to regain compliance by December 31, 2025, through recent financing activities, investors should closely monitor the situation as failure to meet Nasdaq's requirements could lead to delisting.


check_boxEventos clave

  • Nasdaq Non-Compliance Notification

    SciSparc Ltd. received a notification from Nasdaq for failing to meet the minimum $2.5 million stockholders' equity requirement, reporting approximately $(81,000) as of June 30, 2025.

  • Compliance Plan Deadline

    The company has 45 calendar days, until February 26, 2026, to submit a plan to regain compliance with Nasdaq's listing rules.

  • Expected Resolution

    SciSparc anticipates regaining compliance by December 31, 2025, citing proceeds from a $4.2 million debenture conversion in August 2025 and a registered direct offering in November 2025.


auto_awesomeAnalisis

SciSparc Ltd. has received a notification from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement, reporting a negative equity balance of approximately $(81,000) as of June 30, 2025, significantly below the $2.5 million threshold. This notice highlights severe financial distress and poses a material risk to the company's Nasdaq listing if not resolved. While the company expects to regain compliance by December 31, 2025, through recent financing activities, investors should closely monitor the situation as failure to meet Nasdaq's requirements could lead to delisting.

En el momento de esta presentación, SPRC cotizaba a 1,45 $ en NASDAQ dentro del sector Life Sciences, con una capitalización de mercado de aproximadamente 4,8 M$. El rango de cotización de 52 semanas fue de 1,25 $ a 19,09 $. Este documento fue evaluado con un sentimiento de mercado negativo y una puntuación de importancia de 8 sobre 10.

descriptionVer presentacion principal de la SEC

show_chartGrafico de precios

Compartir este articulo

Copied!

feed SPRC - Ultimos analisis

SPRC
Apr 29, 2026, 4:20 PM EDT
Filing Type: 20-F
Importance Score:
9
SPRC
Mar 16, 2026, 8:21 AM EDT
Source: Reuters
Importance Score:
7
SPRC
Mar 12, 2026, 4:41 PM EDT
Filing Type: 6-K
Importance Score:
8
SPRC
Mar 12, 2026, 7:55 AM EDT
Source: GlobeNewswire
Importance Score:
7
SPRC
Mar 10, 2026, 9:28 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
SPRC
Mar 02, 2026, 8:08 AM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 17, 2026, 5:27 PM EST
Filing Type: F-3
Importance Score:
9
SPRC
Feb 17, 2026, 4:01 PM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 12, 2026, 4:02 PM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 03, 2026, 4:36 PM EST
Filing Type: F-3
Importance Score:
9